Effect of eculizumab administrations on the haemostatic changes in patients with paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Seregina, E. [1 ]
Nikulina, O. [2 ]
Tsvetaeva, N. [2 ]
Balandina, A. [3 ]
Ataullakhanov, F. [4 ]
机构：
[1] HemaCore LLC, Moscow, Russia
[2] Natl Res Ctr Hematol, Moscow, Russia
[3] Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
[4] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：836 / 836
页数：1
相关论文
共 50 条
  • [1] Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E. A.
    Tsvetaeva, N. V.
    Nikulina, O. F.
    Zapariy, A. P.
    Erasov, A. V.
    Gribkova, I. V.
    Orel, E. B.
    Ataullakhanov, F. I.
    Balandina, A. N.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (02) : 144 - 150
  • [2] Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
    Marti-Carvajal, Arturo J.
    Anand, Vidhu
    Felipe Cardona, Andres
    Sola, Ivan
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [3] Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kelly, Richard J.
    Hoechsmann, Britta
    Szer, Jeff
    Kulasekararaj, Austin
    Path, F. R. C.
    de Guibert, Sophie
    Roeth, Alexander
    Weitz, Ilene C.
    Armstrong, Elina
    Risitano, Antonio M.
    Patriquin, Christopher J.
    Terriou, Louis
    Muus, Petra
    Hill, Anita
    Turner, Michelle P.
    Schrezenmeier, Hubert
    de latour, Regis Peffault
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11): : 1032 - 1039
  • [4] Paroxysmal nocturnal hemoglobinuria and eculizumab
    Luzzatto, Lucio
    Risitano, Antonio Maria
    Notaro, Rosario
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 523 - 526
  • [5] Eculizumab in paroxysmal nocturnal hemoglobinuria
    Socie, Gerard
    Varoqueaux, Nathalie
    de Latour, Regis Peffault
    [J]. M S-MEDECINE SCIENCES, 2009, 25 (12): : 1126 - 1129
  • [6] Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P
    Hall, C
    Marsh, JCW
    Elebute, M
    Bombara, MP
    Petro, BE
    Cullen, MJ
    Richards, SJ
    Rollins, SA
    Mojcik, CF
    Rother, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06): : 552 - 559
  • [7] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    [J]. BLOOD, 2007, 110 (12) : 4123 - 4128
  • [8] Effect of eculizumab therapy on the coagulation status of patients with paroxysmal nocturnal hemoglobinuria
    Gribkova, I
    Tsvetaeva, N.
    Seregina, E.
    Nikulina, O.
    Balandina, A.
    Gorbatenko, A.
    Sinauridze, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 13 - 13
  • [9] Survival benefit of eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Patel, Ami
    Metzger, Jesse
    Terriou, Louis
    Patriquin, Christopher
    Griffin, Morag
    Lee, Jong Wook
    Gustovic, Phillippe
    Jiang, Wei
    Szer, Jeff
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 264 - 265
  • [10] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
12345